HMT Named Top 10 CRO in Europe
HMT is granted patent for MDD biomarker in the EU
HMT enters strategic partnership in China
HMT publishes on first diagnostic biomarker for MDD
HMT to develop clinical assay for MDD biomarker
HMT collaboration with NIH/NIA to study Alzheimer’s
HMT develops assay kit for depression biomarker
HMT joins NIH OSTR Subsidy Program
HMT Names Alex Buko as VP of Biomarker Development